{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:07:30Z","timestamp":1787731650171,"version":"build-2784847793"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Clinics of North America: Equine Practice"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.cveq.2019.04.003","type":"journal-article","created":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T10:31:10Z","timestamp":1562149870000},"page":"311-325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Treatment Options for Melanoma of Gray Horses"],"prefix":"10.1016","volume":"35","author":[{"given":"Robert J.","family":"MacKay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cveq.2019.04.003_bib1","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/ng.185","article-title":"A\u00a0cis-acting regulatory mutation causes premature hair graying and susceptibility to melanoma in the horse","volume":"40","author":"Pielberg","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.cveq.2019.04.003_bib2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/1471-2164-13-365","article-title":"Copy number expansion of the STX17 duplication in melanoma tissue from Grey horses","volume":"13","author":"Sundstrom","year":"2012","journal-title":"BMC Genomics"},{"key":"10.1016\/j.cveq.2019.04.003_bib3","doi-asserted-by":"crossref","first-page":"e1003248","DOI":"10.1371\/journal.pgen.1003248","article-title":"Complex inheritance of melanoma and pigmentation of coat and skin in Grey horses","volume":"9","author":"Curik","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1016\/j.cveq.2019.04.003_bib4","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/jvim.12133","article-title":"Coat color genotypes and risk and severity of melanoma in gray quarter horses","volume":"27","author":"Teixeira","year":"2013","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cveq.2019.04.003_bib5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5114\/pdia.2013.33376","article-title":"Skin melanocytes: biology and development","volume":"30","author":"Cichorek","year":"2013","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1016\/j.cveq.2019.04.003_bib6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2746\/042516403776114234","article-title":"Equine melanoma in a population of 296 grey Lipizzaner horses","volume":"35","author":"Seltenhammer","year":"2003","journal-title":"Equine Vet J"},{"key":"10.1016\/j.cveq.2019.04.003_bib7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1034\/j.1600-0749.2000.130109.x","article-title":"The study of cutaneous melanomas in Camargue-type gray-skinned horses (2): Epidemiological survey","volume":"13","author":"Fleury","year":"2000","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.cveq.2019.04.003_bib8","doi-asserted-by":"crossref","first-page":"443","DOI":"10.17221\/8524-CJAS","article-title":"Characterization of greying, melanoma, and vitiligo quantitative inheritance in Old Kladruber horses","volume":"60","author":"Hofmanova","year":"2015","journal-title":"Czech J Anim Sci"},{"key":"10.1016\/j.cveq.2019.04.003_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1034\/j.1600-0749.2000.130108.x","article-title":"The study of cutaneous melanomas in Camargue-type gray-skinned horses (1): Clinical-pathological characterization","volume":"13","author":"Fleury","year":"2000","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.cveq.2019.04.003_bib10","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/1821531a0","article-title":"Coat-colour and longevity in thoroughbred mares","volume":"182","author":"Comfort","year":"1958","journal-title":"Nature"},{"key":"10.1016\/j.cveq.2019.04.003_bib11","doi-asserted-by":"crossref","first-page":"455","DOI":"10.21836\/PEM20140410","article-title":"Aetiology, clinical presentation and current treatment options of equine malignant melanoma - a review of the literature Abstracts","volume":"30","author":"Cavalleri","year":"2014","journal-title":"Pferdeheilkunde"},{"key":"10.1016\/j.cveq.2019.04.003_bib12","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.cveq.2013.08.008","article-title":"Equine melanocytic tumors","volume":"29","author":"Phillips","year":"2013","journal-title":"Vet Clin North Am Equine Pract"},{"key":"10.1016\/j.cveq.2019.04.003_bib13","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0749-0739(17)30190-6","article-title":"Dermatologic tumors (excluding sarcoids)","volume":"14","author":"Johnson","year":"1998","journal-title":"Vet Clin North Am Equine Pract"},{"key":"10.1016\/j.cveq.2019.04.003_bib14","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/eve.12767","article-title":"Surgical excision of large melanocytic tumours in grey horses: 38 cases (2001-2013)","volume":"30","author":"Groom","year":"2018","journal-title":"Equine Vet Educ"},{"key":"10.1016\/j.cveq.2019.04.003_bib15","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0749-0739(17)30191-8","article-title":"Intralesional and topical chemotherapy and immunotherapy","volume":"14","author":"Theon","year":"1998","journal-title":"Vet Clin North Am Equine Pract"},{"key":"10.1016\/j.cveq.2019.04.003_bib16","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.2460\/javma.230.10.1506","article-title":"Long-term outcome associated with intratumoral chemotherapy with cisplatin for cutaneous tumors in equidae: 573 cases (1995-2004)","volume":"230","author":"Theon","year":"2007","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cveq.2019.04.003_bib17","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2460\/javma.229.10.1617","article-title":"Use of cisplatin-containing biodegradable beads for treatment of cutaneous neoplasia in equidae: 59 cases (2000-2004)","volume":"229","author":"Hewes","year":"2006","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cveq.2019.04.003_bib18","series-title":"Current therapy in equine medicine","first-page":"372","article-title":"Cisplatin treatment of cutaneous tumors","author":"Theon","year":"1997"},{"key":"10.1016\/j.cveq.2019.04.003_bib19","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.ejso.2016.06.399","article-title":"Treatment efficacy with electrochemotherapy: a multi-institutional prospective observational study on 376 patients with superficial tumors","volume":"42","author":"Campana","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.cveq.2019.04.003_bib20","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1939-1676.2008.0117.x","article-title":"Electrochemotherapy in veterinary oncology","volume":"22","author":"Cemazar","year":"2008","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cveq.2019.04.003_bib21","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.2042-3306.2011.00425.x","article-title":"Successful treatment of equine sarcoids with cisplatin electrochemotherapy: a retrospective study of 48 cases","volume":"44","author":"Tamzali","year":"2012","journal-title":"Equine Vet J"},{"key":"10.1016\/j.cveq.2019.04.003_bib22","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jevs.2011.01.009","article-title":"Electrochemotherapy for the treatment of multiple melanomas in a horse","volume":"31","author":"Spugnini","year":"2011","journal-title":"J\u00a0Equine Vet Sci"},{"key":"10.1016\/j.cveq.2019.04.003_bib23","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jevs.2012.09.006","article-title":"Adjuvant electrochemotherapy increases local control in a recurring equine anal melanoma","volume":"33","author":"Scacco","year":"2013","journal-title":"J\u00a0Equine Vet Sci"},{"key":"10.1016\/j.cveq.2019.04.003_bib24","article-title":"Immunotherapy, radiotherapy, and hyperthermia: a combined therapeutic approach in pancreatic cancer treatment","volume":"10","author":"Mahmood","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.cveq.2019.04.003_bib25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.2042-3292.2004.tb00319.x","article-title":"Use of radiation therapy in the treatment of equine neoplasia","volume":"16","author":"Henson","year":"2004","journal-title":"Equine Vet Educ"},{"key":"10.1016\/j.cveq.2019.04.003_bib26","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/vru.12345","article-title":"Computed tomographic appearance of melanomas in the equine head: 13 cases","volume":"57","author":"Dixon","year":"2016","journal-title":"Vet Radiol Ultrasound"},{"key":"10.1016\/j.cveq.2019.04.003_bib27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/eve.12420","article-title":"Electronic brachytherapy used for the successful treatment of three different types of equine tumours","volume":"29","author":"Bradley","year":"2017","journal-title":"Equine Vet Educ"},{"key":"10.1016\/j.cveq.2019.04.003_bib28","article-title":"A\u00a0review of immunotherapeutic strategies in canine malignant melanoma","volume":"6","author":"Almela","year":"2019","journal-title":"Vet Sci"},{"key":"10.1016\/j.cveq.2019.04.003_bib29","first-page":"1","article-title":"Cancer immunotherapy","volume":"26","author":"Dillman","year":"2011","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.cveq.2019.04.003_bib30","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s001090000165","article-title":"Tumor regression induced by intratumoral injection of DNA coding for human interleukin 12 into melanoma metastases in gray horses","volume":"78","author":"Heinzerling","year":"2001","journal-title":"J Mol Med"},{"key":"10.1016\/j.cveq.2019.04.003_bib31","first-page":"58","article-title":"Double-blind placebo-controlled study with interleukin-18 and interleukin-12-encoding plasmid DNA shows antitumor effect in metastatic melanoma in gray horses","volume":"34","author":"Muller","year":"2011","journal-title":"J\u00a0Immunother"},{"key":"10.1016\/j.cveq.2019.04.003_bib32","doi-asserted-by":"crossref","DOI":"10.1186\/s12917-015-0422-9","article-title":"Local and systemic effect of transfection-reagent formulated DNA vectors on equine melanoma","volume":"11","author":"Mahlmann","year":"2015","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.cveq.2019.04.003_bib33","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1056\/NEJMe1205943","article-title":"Tumor immunotherapy directed at PD-1","volume":"366","author":"Ribas","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cveq.2019.04.003_bib34","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1159\/000007686","article-title":"Does cimetidine improve prospects for cancer patients?. A reappraisal of the evidence to date","volume":"60","author":"Siegers","year":"1999","journal-title":"Digestion"},{"key":"10.1016\/j.cveq.2019.04.003_bib35","first-page":"1021","article-title":"Cimetidine, an unexpected anti-tumor agent, and its potential for the treatment of glioblastoma","volume":"28","author":"Lefranc","year":"2006","journal-title":"Int J Oncol"},{"key":"10.1016\/j.cveq.2019.04.003_bib36","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2460\/javma.1990.196.03.449","article-title":"Cimetidine for treatment of melanomas in 3 horses","volume":"196","author":"Goetz","year":"1990","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cveq.2019.04.003_bib37","first-page":"608","article-title":"Treatment of melanomas in horses","volume":"15","author":"Goetz","year":"1993","journal-title":"Compend Contin Educ Vet"},{"key":"10.1016\/j.cveq.2019.04.003_bib38","first-page":"18","article-title":"Cimetidine for the treatment of melanomas in horses - efficacy determined by client questionnaire","volume":"16","author":"Hare","year":"1994","journal-title":"Equine Pract"},{"key":"10.1016\/j.cveq.2019.04.003_bib39","first-page":"48","article-title":"Evaluation of cimetidine as a therapy for dermal melanomatosis in grey horse","volume":"65","author":"Laus","year":"2010","journal-title":"Refu Vet"},{"key":"10.1016\/j.cveq.2019.04.003_bib40","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.2042-3306.1990.tb04206.x","article-title":"Pharmacokinetic studies of cimetidine hydrochloride in adult horses","volume":"22","author":"Smyth","year":"1990","journal-title":"Equine Vet J"},{"key":"10.1016\/j.cveq.2019.04.003_bib41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S1040-8428(02)00014-8","article-title":"Adjuvant therapy of malignant melanoma","volume":"44","author":"Molife","year":"2002","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.cveq.2019.04.003_bib42","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/jvim.15404","article-title":"Can levamisole upregulate the equine cell-mediated macrophage (M1) dendritic cell (DC1) T-helper 1 (CD4 Th1) T-cytotoxic (CD8) immune response in\u00a0vitro?","volume":"33","author":"Witonsky","year":"2019","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cveq.2019.04.003_bib43","first-page":"1","article-title":"Decoquinate combined with levamisole reduce the clinical signs and serum SAG 1, 5, 6 antibodies in horses with suspected equine protozoal myeloencephalitis","volume":"10","author":"Ellison","year":"2012","journal-title":"Int J Appl Res Vet Med"},{"key":"10.1016\/j.cveq.2019.04.003_bib44","series-title":"Current therapy in equine medicine","first-page":"399","article-title":"Melanomas","author":"Jeglum","year":"1997"},{"key":"10.1016\/j.cveq.2019.04.003_bib45","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/2046-0481-66-22","article-title":"Malignant melanoma in a grey horse: case presentation and review of equine melanoma treatment options","volume":"66","author":"Metcalfe","year":"2013","journal-title":"Ir Vet J"},{"key":"10.1016\/j.cveq.2019.04.003_bib46","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.vetimm.2006.08.012","article-title":"The immune response to disialoganglioside GD3 vaccination in normal dogs: a melanoma surface antigen vaccine","volume":"114","author":"Milner","year":"2006","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.cveq.2019.04.003_bib47","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jevs.2013.11.012","article-title":"Treatment of metastatic equine melanoma with a plasmid DNA vaccine encoding Streptococcus pyogenes EMM55 protein","volume":"34","author":"Brown","year":"2014","journal-title":"J\u00a0Equine Vet Sci"}],"container-title":["Veterinary Clinics of North America: Equine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749073919300240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749073919300240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T04:17:24Z","timestamp":1760069844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749073919300240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0749073919300240"],"URL":"https:\/\/doi.org\/10.1016\/j.cveq.2019.04.003","relation":{},"ISSN":["0749-0739"],"issn-type":[{"value":"0749-0739","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment Options for Melanoma of Gray Horses","name":"articletitle","label":"Article Title"},{"value":"Veterinary Clinics of North America: Equine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cveq.2019.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}